Nata Komplete, containing one 30-count bottle of multi-vitamin tablets (imprinted 909), Manufactu...

FDA Drug Recall #D-900-2013 — Class III — June 28, 2013

Recall Summary

Recall Number D-900-2013
Classification Class III — Low risk
Date Initiated June 28, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Stayma Consulting Service, LLC.
Location Suwanee, GA
Product Type Drugs
Quantity 1974 and 3967 physician samples

Product Description

Nata Komplete, containing one 30-count bottle of multi-vitamin tablets (imprinted 909), Manufactured for W.H. Nutritionals, Wilmington, DE (NDC 76331-909-30) and physician samples of nine bottles of 5-multi-vitamin tablets (NDC 76331-909-05 )

Reason for Recall

Subpotent; Beta carotene (Vitamin A)

Distribution Pattern

Nationwide.

Lot / Code Information

NDC 76331-909-30; Lot 40186, exp 5/14 NDC 76331-909-05; Lot 40186, exp. 5/14 (physician samples)

Other Recalls from Stayma Consulting Service, LLC.

Recall # Classification Product Date
D-897-2013 Class III NataChew, 1) one 90-count bottle of multi-vitam... Jun 28, 2013
D-899-2013 Class III Duet DHA 430 ec, containing one 30-count bottle... Jun 28, 2013
D-898-2013 Class III Duet DHA 430, containing one 30-count bottle of... Jun 28, 2013
D-895-2013 Class III Duet DHA 400, containing one 30-count bottle of... Jun 28, 2013
D-894-2013 Class III Duet DHA Balanced, 1) 30 count tablet blister c... Jun 28, 2013

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.